Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 Dec;77(12):766–770. doi: 10.1136/bjo.77.12.766

Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.

J N Kirkpatrick 1, A D Dick 1, J V Forrester 1
PMCID: PMC504651  PMID: 7509185

Abstract

There has been recent interest in the use of systemic interferon alfa-2a treatment for choroidal neovascular membranes (CNV). Here a pilot study is reported in which 10 patients with exudative age-related macular degeneration (ARMD) have been treated with a course of interferon injections. Of nine eyes with CNV there has been clinical and angiographic improvement in one eye and maintenance of visual acuity at pretreatment levels in three eyes (mean follow up period 7.6 months). Clinical appearance in five eyes was unchanged but these eyes still had active CNV. Two eyes with pigment epithelial detachment showed no clinical or angiographic change after interferon therapy although visual acuity in one eye had improved. Interferon alfa-2a may have a role to play in the treatment of ARMD as an adjunct to laser photocoagulation.

Full text

PDF
766

Images in this article

768Image
on p.768

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird A. C. Doyne Lecture. Pathogenesis of retinal pigment epithelial detachment in the elderly; the relevance of Bruch's membrane change. Eye (Lond) 1991;5(Pt 1):1–12. doi: 10.1038/eye.1991.2. [DOI] [PubMed] [Google Scholar]
  2. Bressler N. M., Bressler S. B., Gragoudas E. S. Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol. 1987 Feb;105(2):209–213. doi: 10.1001/archopht.1987.01060020063030. [DOI] [PubMed] [Google Scholar]
  3. Bressler S. B., Bressler N. M., Fine S. L., Hillis A., Murphy R. P., Olk R. J., Patz A. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol. 1982 Feb;93(2):157–163. doi: 10.1016/0002-9394(82)90410-x. [DOI] [PubMed] [Google Scholar]
  4. Brouty-Boyé D., Zetter B. R. Inhibition of cell motility by interferon. Science. 1980 May 2;208(4443):516–518. doi: 10.1126/science.6154315. [DOI] [PubMed] [Google Scholar]
  5. Coscas G., Soubrane G., Ramahefasolo C., Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol. 1991 Sep;109(9):1258–1265. doi: 10.1001/archopht.1991.01080090082028. [DOI] [PubMed] [Google Scholar]
  6. Coscas G., Soubrane G., Ramahefasolo C., Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol. 1991 Sep;109(9):1258–1265. doi: 10.1001/archopht.1991.01080090082028. [DOI] [PubMed] [Google Scholar]
  7. Feldman D., Goldstein A. L., Cox D. C., Grimley P. M. Cultured human endothelial cells treated with recombinant leukocyte A interferon. Tubuloreticular inclusion formation, antiproliferative effect, and 2',5' oligoadenylate synthetase induction. Lab Invest. 1988 May;58(5):584–589. [PubMed] [Google Scholar]
  8. Ferris F. L., 3rd, Fine S. L., Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984 Nov;102(11):1640–1642. doi: 10.1001/archopht.1984.01040031330019. [DOI] [PubMed] [Google Scholar]
  9. Folkman J., Klagsbrun M. Angiogenic factors. Science. 1987 Jan 23;235(4787):442–447. doi: 10.1126/science.2432664. [DOI] [PubMed] [Google Scholar]
  10. Friesel R., Komoriya A., Maciag T. Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol. 1987 Mar;104(3):689–696. doi: 10.1083/jcb.104.3.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fung W. E. Interferon alpha 2a for treatment of age-related macular degeneration. Am J Ophthalmol. 1991 Sep 15;112(3):349–350. doi: 10.1016/s0002-9394(14)76743-1. [DOI] [PubMed] [Google Scholar]
  12. Fung W. E. Interferon alpha 2a for treatment of age-related macular degeneration. Am J Ophthalmol. 1991 Sep 15;112(3):349–350. doi: 10.1016/s0002-9394(14)76743-1. [DOI] [PubMed] [Google Scholar]
  13. Grey R. H., Burns-Cox C. J., Hughes A. Blind and partial sight registration in Avon. Br J Ophthalmol. 1989 Feb;73(2):88–94. doi: 10.1136/bjo.73.2.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Guyer D. R., Fine S. L., Maguire M. G., Hawkins B. S., Owens S. L., Murphy R. P. Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Arch Ophthalmol. 1986 May;104(5):702–705. doi: 10.1001/archopht.1986.01050170092029. [DOI] [PubMed] [Google Scholar]
  15. Guyer D. R., Tiedeman J., Yannuzzi L. A., Slakter J. S., Parke D., Kelley J., Tang R. A., Marmor M., Abrams G., Miller J. W. Interferon-associated retinopathy. Arch Ophthalmol. 1993 Mar;111(3):350–356. doi: 10.1001/archopht.1993.01090030068041. [DOI] [PubMed] [Google Scholar]
  16. Miller J. W., Stinson W. G., Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993 Jan;100(1):9–14. doi: 10.1016/s0161-6420(93)31712-4. [DOI] [PubMed] [Google Scholar]
  17. Orchard P. J., Smith C. M., 3rd, Woods W. G., Day D. L., Dehner L. P., Shapiro R. Treatment of haemangioendotheliomas with alpha interferon. Lancet. 1989 Sep 2;2(8662):565–567. doi: 10.1016/s0140-6736(89)90694-6. [DOI] [PubMed] [Google Scholar]
  18. Orchard P. J., Smith C. M., 3rd, Woods W. G., Day D. L., Dehner L. P., Shapiro R. Treatment of haemangioendotheliomas with alpha interferon. Lancet. 1989 Sep 2;2(8662):565–567. doi: 10.1016/s0140-6736(89)90694-6. [DOI] [PubMed] [Google Scholar]
  19. Orchard P. J., Smith C. M., 3rd, Woods W. G., Day D. L., Dehner L. P., Shapiro R. Treatment of haemangioendotheliomas with alpha interferon. Lancet. 1989 Sep 2;2(8662):565–567. doi: 10.1016/s0140-6736(89)90694-6. [DOI] [PubMed] [Google Scholar]
  20. Phillips R. P., Spencer T., Ross P. G., Sharp P. F., Forrester J. V. Quantification of diabetic maculopathy by digital imaging of the fundus. Eye (Lond) 1991;5(Pt 1):130–137. doi: 10.1038/eye.1991.24. [DOI] [PubMed] [Google Scholar]
  21. Sarks S. H. Council Lecture. Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol. 1980 May;8(2):117–130. doi: 10.1111/j.1442-9071.1980.tb01670.x. [DOI] [PubMed] [Google Scholar]
  22. Scheider A., Kaboth A., Neuhauser L. Detection of subretinal neovascular membranes with indocyanine green and an infrared scanning laser ophthalmoscope. Am J Ophthalmol. 1992 Jan 15;113(1):45–51. doi: 10.1016/s0002-9394(14)75752-6. [DOI] [PubMed] [Google Scholar]
  23. Sidky Y. A., Borden E. C. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res. 1987 Oct 1;47(19):5155–5161. [PubMed] [Google Scholar]
  24. Teeters V. W., Bird A. C. A clinical study of the vascularity of senile disciform macular degeneration. Am J Ophthalmol. 1973 Jan;75(1):53–65. doi: 10.1016/0002-9394(73)90652-1. [DOI] [PubMed] [Google Scholar]
  25. Teeters V. W., Bird A. C. The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol. 1973 Jul;76(1):1–18. doi: 10.1016/0002-9394(73)90002-0. [DOI] [PubMed] [Google Scholar]
  26. Thompson J. R., Du L., Rosenthal A. R. Recent trends in the registration of blindness and partial sight in Leicestershire. Br J Ophthalmol. 1989 Feb;73(2):95–99. doi: 10.1136/bjo.73.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. White C. W., Sondheimer H. M., Crouch E. C., Wilson H., Fan L. L. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med. 1989 May 4;320(18):1197–1200. doi: 10.1056/NEJM198905043201807. [DOI] [PubMed] [Google Scholar]
  28. White C. W., Sondheimer H. M., Crouch E. C., Wilson H., Fan L. L. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med. 1989 May 4;320(18):1197–1200. doi: 10.1056/NEJM198905043201807. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES